Net profit of IOL Chemicals & Pharmaceuticals rose 0.24% to Rs 20.58 crore in the quarter ended December 2025 as against Rs 20.53 crore during the previous quarter ended December 2024. Sales rose 10.91% to Rs 580.39 crore in the quarter ended December 2025 as against Rs 523.30 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales580.39523.30 11 OPM %9.878.96 - PBDT58.9446.48 27 PBT38.7627.80 39 NP20.5820.53 0 Powered by Capital Market - Live News

IOL Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 11 February 2026, inter alia, have recommended the interim dividend of Rs 1 per equity Share (i.e. 50%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

IOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News

Net profit of IOL Chemicals & Pharmaceuticals rose 56.50% to Rs 29.97 crore in the quarter ended September 2025 as against Rs 19.15 crore during the previous quarter ended September 2024. Sales rose 7.95% to Rs 567.53 crore in the quarter ended September 2025 as against Rs 525.75 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales567.53525.75 8 OPM %10.067.91 - PBDT60.4843.88 38 PBT40.4925.94 56 NP29.9719.15 57 Powered by Capital Market - Live News

IOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live News